Evaluation of the natural course of thyroid nodules in patients with acromegaly.
Acromegaly
IGF-1
Natural course
Papillary thyroid carcinoma
Thyroid nodule growth
Journal
Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
16
11
2018
medline:
5
3
2019
entrez:
16
11
2018
Statut:
ppublish
Résumé
To investigate the nodular thyroid disease (NTD) and the natural course of thyroid nodules in patients with acromegaly. 138 patients with acromegaly (73 F/65 M), whose initial thyroid ultrasonography performed in our university hospital, were included in this study. The frequencies of NTD, papillary thyroid cancer (PTC) and associated factors on nodule formation were investigated at initial assessment. Patients who had NTD continued to follow-up (n = 56) were re-evaluated with a ultrasonography performed after a mean 7-years follow-up period. The nodule size changes were compared with the initial data and the factors affecting nodule growth were investigated. The frequency of NTD was found 69%. Patients with NTD were older (p = 0.05), with higher baseline IGF-1%ULN (upper limit of normal) (p = 0.01). In patients with NTD, the majority had similar nodule size (45%), decreased nodule size in 30% and nodule growth in 25%. In patients with active acromegaly at last visit, nodule growth was more significant (p < 0.001). For one unit change in the IGF-1 levels, nodule growth increased by 1.01 folds and presence of active acromegaly disease was related with ninefolds increase in nodule growth. The frequency of PTC was 14% in patients with nodule growth and PTC was diagnosed 11% of all acromegalic patients. Both NTD and nodule growth is more frequent in active acromegalic patients. Thyroid nodules may show dynamic changes according to the disease activity and nodule growth should be closely monitored due to the risk of malignancy in patients with active acromegaly disease.
Identifiants
pubmed: 30430336
doi: 10.1007/s11102-018-0923-1
pii: 10.1007/s11102-018-0923-1
doi:
Substances chimiques
Antigens, CD
0
Antigens, Differentiation, Myelomonocytic
0
CD68 antigen, human
0
GFAP protein, human
0
Glial Fibrillary Acidic Protein
0
Receptors, Somatostatin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
29-36Références
Thyroid. 1999 Nov;9(11):1069-74
pubmed: 10595454
Eur J Endocrinol. 2000 Mar;142(3):224-30
pubmed: 10700715
Radiology. 2000 Jun;215(3):801-6
pubmed: 10831702
Horm Metab Res. 2000 May;32(5):190-5
pubmed: 10871160
J Clin Endocrinol Metab. 2001 Sep;86(9):4089-91
pubmed: 11549630
Endocr Rev. 2001 Oct;22(5):631-56
pubmed: 11588145
J Endocrinol Invest. 2001 Nov;24(10):770-6
pubmed: 11765046
J Endocrinol Invest. 2002 Mar;25(3):240-5
pubmed: 11936466
Exp Clin Endocrinol Diabetes. 2002 Oct;110(7):348-54
pubmed: 12397534
Ann Intern Med. 2003 Feb 18;138(4):315-8
pubmed: 12585829
Diabetes Care. 2003 Dec;26(12):3320-5
pubmed: 14633821
Exp Clin Endocrinol Diabetes. 2004 May;112(5):225-30
pubmed: 15146366
N Engl J Med. 2004 Oct 21;351(17):1764-71
pubmed: 15496625
Clin Endocrinol (Oxf). 2005 Aug;63(2):161-7
pubmed: 16060909
Clin Endocrinol (Oxf). 2006 Dec;65(6):767-71
pubmed: 17121528
Horm Metab Res. 1991 Mar;23(3):131-4
pubmed: 1907592
Thyroid. 2009 Nov;19(11):1159-65
pubmed: 19888858
Pituitary. 2010 Sep;13(3):242-8
pubmed: 20217483
Endocr Res. 2011;36(4):167-74
pubmed: 21973236
Pituitary. 2013 Mar;16(1):109-14
pubmed: 22527615
Pituitary. 2013 Sep;16(3):294-302
pubmed: 22903574
Endocrine. 2013 Aug;44(1):158-64
pubmed: 23288662
Metabolism. 2013 Jul;62(7):970-5
pubmed: 23395200
Endocrine. 2014 Feb;45(1):114-21
pubmed: 23670709
Pituitary. 2014 Aug;17(4):299-306
pubmed: 23836362
Endocrinol Metab (Seoul). 2013 Jun;28(2):110-8
pubmed: 24396664
Arq Bras Endocrinol Metabol. 2013 Dec;57(9):685-90
pubmed: 24402013
Radiology. 2014 Apr;271(1):272-81
pubmed: 24475857
PLoS One. 2014 Feb 14;9(2):e88787
pubmed: 24551163
PLoS One. 2014 Aug 15;9(8):e104174
pubmed: 25127456
PLoS One. 2014 Oct 17;9(10):e110241
pubmed: 25329702
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51
pubmed: 25356808
Acta Endocrinol (Copenh). 1989 Jul;121(1):112-20
pubmed: 2545061
J Am Coll Surg. 2015 Jun;220(6):987-92
pubmed: 25667137
JAMA. 2015 Mar 3;313(9):926-35
pubmed: 25734734
Thyroid. 2015 Oct;25(10):1115-20
pubmed: 26148539
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
N Engl J Med. 2015 Dec 10;373(24):2347-56
pubmed: 26650154
Diabetes Care. 2016 Jan;39 Suppl 1:S13-22
pubmed: 26696675
Pituitary. 2017 Feb;20(1):70-75
pubmed: 27631334
J BUON. 2016 Jul-Aug;21(4):989-993
pubmed: 27685924
Endokrynol Pol. 2017;68(1):2-6
pubmed: 28255974
Int J Endocrinol. 2017;2017:8401518
pubmed: 28356911
Endocr Relat Cancer. 2017 Sep;24(9):495-504
pubmed: 28710115
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647
pubmed: 29040691
Clin Endocrinol (Oxf). 1997 May;46(5):545-9
pubmed: 9231049